Close

Stuck in FUS – the story of arginines, MND and FTD

Reading Time: 5 minutes In recent news, a number of press releases highlighted a paper published in the journal Cell, in which scientists, under the leadership of the University of Toronto’s Professor Peter St George-Hyslop, and in collaboration with University of Cambridge, described the process of how the FUS protein leads to the development of motor neurone disease (MND)…

Tirasemtiv not found effective for treatment of MND

Tirasemtiv not found effective for treatment of MND

Reading Time: 2 minutes In their official press release published on 21 November 2017, Cytokinetics Inc. announced that they will not be continuing work on tirasemtiv after disappointing results in the latest Phase 3 clinical trial. The trial, known under the acronym ‘VITALITY-ALS’, tested whether the drug has a beneficial effect on the breathing function and muscle strength of…

Networking to progress in the world of science: Mini-Symposium on MND

Reading Time: 5 minutes Conferences and symposia are a crucial part of the research world – not only for the amount of knowledge that is communicated to large audiences but also for the exchange of ideas on a more inter-personal level. Novel ideas are created there as well establishment of collaborations that might lead to new research projects and…

Shining a light on our non-clinical fellow: Using blue light to control muscle movement

Reading Time: 4 minutes The MND Association is proud to support the brightest minds of MND research. Outside of general healthcare and biomedical project grants that are usually awarded to senior researchers, we also offer opportunities to young researchers – these take the form of PhD studentships and fellowships. Fellowships are awarded to post-doctoral researchers who are able to…